Biological properties of the m-44 strain of coxiella burneti

Journal of Infectious Diseases

Volumn 133, Issue 3, 1976, Pages 334-338

  Johnson, James W ^a   Eddy, Gerald A ^a   Pedersen, Carl E ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; RICKETTSIA VACCINE; VACCINE;

ANIMAL; ANTIBODY PRODUCTION; ARTICLE; DRUG EFFECT; FEMALE; GUINEA PIG; IMMUNOLOGY; MALE; MICROBIOLOGY; PREGNANCY; Q FEVER; VACCINATION;

ANIMAL; ANTIBODY FORMATION; ANTIGENS; CYCLOPHOSPHAMIDE; FEMALE; GUINEA PIGS; MALE; METHYLPREDNISOLONE; PREGNANCY; Q FEVER; RICKETTSIAL VACCINES; VACCINATION; VACCINES;

EID: 0016931126     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/133.3.334     Document Type: Article

References (18)

1. Genig, V. A. Attenuated variant M of Rickettsia burneti as a possible live vaccine against Q fever. Vestn. Akad. Med. Nauk S. S. S. R. 15(2): 46-57, 1960.
2. Genig, V. A., Kniazeva, E. N., Tselnikov, P. S., Miroshnichenko, M. M. Experience on the mass immunization of humans with the M-44 live vaccine against Q-fever. I. Subcutaneous method of immunization. Vopr. Virusol. 10: 319-323, 1965.
3. Sterkhova, A. N. Immunization of humans with M-44 live vaccine against Q-fever. Zh. Mikrobiol. Epidemiol. Immunobiol. 42(12): 48-52, 1965.
4. Zdrodovskiy, P. F., Genig, V. A. The problem of a live vaccine against Q fever. Vopr. Virusol. 7: 355-358, 1962.
5. Robinson, D. M., Hasty, S. E. Production of a potent vaccine from the attenuated M-44 strain of Coxiella burneti. Appl. Microbiol. 27: 777-783, 1974.
6. Fiset, P., Ormsbee, R. A., Silberman, R., Peacock, M., Spielman, S. H. A microagglutination technique for detection and measurement of rickettsial antibodies. Acta Virol. (Praha) 13: 60-66, 1969.
7. Ormsbee, R. A. A method of purifying Coxiella burneti and other pathogenic rickettsiae. J. Immunol. 88: 100-108, 1962.
8. Brezina, R., Urvölgyi, J. Study of the antigenic structure of Coxiella burneti. I. Extraction of phase I antigenic component by means of trichloroacetic acid. Acta Virol (Praha) 6: 84-88, 1962.
9. Casey, H. L. Standardized diagnostic complement fixation method and adaptation to micro test. II. Adaptation of the LBCF method to microtechnique. Public Health Monogr. 74: 31-34, 1965.
10. Berman, S., Gochenour, R. B., Cole, G., Lowenthal, J. P., Benenson, A. S. Method for the production of a purified Q fever vaccine. J. Bacteriol. 81: 794-799, 1961.
11. Giménez, D. F. Staining rickettsiae in yolk sac cultures. Stain Technol. 39: 135-140, 1964.
12. Puck, T. T., Cieciura, S. J., Fisher, H. W. Clonal growth in vitro of human cells with fibroblastic morphology. J. Exp. Med. 106: 145-158, 1957.
13. Brezina, R. A change in the virulence of the Henzerling strain of Coxiella burneti during passage in white mice. Acta Virol (Praha) 2: 220-227, 1958.
14. Genig, V. A. A live vaccine l/M-44 against Q-fever for oral use. J. Hyg. Epidemiol. Microbiol. Immunol. (Praha) 12: 265-273, 1968.
15. Syrůček, L., Sobêslavský, O., Gutvirth, I. Isolation of Coxiella burneti from human placentas. J. Hyg. Epidemiol. Microbiol. Immunol. (Praha) 2: 29-35, 1958.
16. Babudieri, B. Epidemiology, diagnosis, and prophylaxis of Q fever. W. H. O. Monogr. Ser. 19: 157-173, 1953.
17. Sidwell, R. W., Thorpe, B. D., Gebhardt, L. P. Studies of latent Q fever infections. II. Eifects of multiple cortisone injections. Am. J. Hyg. 79: 320-327, 1964.
18. Marmion, B. P. Development of Q-fever vaccines 1937-1967. Med. J. Aust. 2: 1074-1078, 1967.